Answers are grounded in this paper and cite their sources.
Allogeneic hematopoietic stem cell transplantation (HSCT) is widely and safely used for hematological diseases. Severe complications have been overcome by a reduced intensity of conditioning, effective immunosuppressive therapy and anti-infectious agents. However, complications after HSCT including GVHD occur with some frequency. Gastrointestinal complications have a relatively high incidence and some influence mortality. The diagnosis of these complications should be confirmed by pathological diagnosis. In this review paper, I discuss the differential diagnosis of gut GVHD and intestinal transplantation associated microangiopathy (i-TAM). i-TAM lesions are ischemic pathological lesions caused by microangiopathy without any allo-cellular reaction. I also mention the pathophysiological mechanism of i-TAM in terms of macrophage studies.
No takes yet. Share an insight, caveat, or question.
Masafumi Ito (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: